These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33316857)

  • 1. Tandem High-dose Chemotherapy without Craniospinal Irradiation in Treatment of Non-metastatic Malignant Brain Tumors in Very Young Children.
    Ma Y; Lim DH; Cho H; Lee JW; Sung KW; Yoo KH; Koo HH; Shin HJ; Suh YL
    J Korean Med Sci; 2020 Dec; 35(48):e405. PubMed ID: 33316857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Atypical Teratoid/Rhabdoid Tumor.
    Sung KW; Lim DH; Yi ES; Choi YB; Lee JW; Yoo KH; Koo HH; Kim JH; Suh YL; Joung YS; Shin HJ
    Cancer Res Treat; 2016 Oct; 48(4):1408-1419. PubMed ID: 27034140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents.
    Lee JW; Lim DH; Sung KW; Lee HJ; Yi ES; Yoo KH; Koo HH; Suh YL; Shin HJ
    J Korean Med Sci; 2017 Feb; 32(2):195-203. PubMed ID: 28049229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of high-dose
    Lee JW; Lee S; Cho HW; Ma Y; Yoo KH; Sung KW; Koo HH; Cho EJ; Lee SK; Lim DH
    J Hematol Oncol; 2017 May; 10(1):108. PubMed ID: 28511709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.
    Sung KW; Lim DH; Son MH; Lee SH; Yoo KH; Koo HH; Kim JH; Suh YL; Joung YS; Shin HJ
    Neuro Oncol; 2013 Mar; 15(3):352-9. PubMed ID: 23258845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.
    Park ES; Sung KW; Baek HJ; Park KD; Park HJ; Won SC; Lim DH; Kim HS
    J Korean Med Sci; 2012 Feb; 27(2):135-40. PubMed ID: 22323859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity of tandem high-dose chemotherapy and autologous stem cell transplantation using carboplatin-thiotepa-etoposide and cyclophosphamide-melphalan regimens for malignant brain tumors in children and young adults.
    Lee SH; Son MH; Sung KW; Choi YB; Lee NH; Yoo KH; Koo HH; Lim DH; Shin HJ
    J Neurooncol; 2014 Dec; 120(3):507-13. PubMed ID: 25108776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.
    Choi JY; Kang HJ; Hong KT; Hong CR; Lee YJ; Park JD; Phi JH; Kim SK; Wang KC; Kim IH; Park SH; Choi YH; Cheon JE; Park KD; Shin HY
    Int J Clin Oncol; 2019 Dec; 24(12):1515-1525. PubMed ID: 31352632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal treatment including tandem high-dose chemotherapy and autologous stem cell transplantation in children with anaplastic ependymomas.
    Lee JW; Lim DH; Sung KW; Lee HJ; Yi ES; Yoo KH; Koo HH; Suh YL; Shin HJ
    Pediatr Transplant; 2018 May; 22(3):e13127. PubMed ID: 29453811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandem high-dose chemotherapy and auto-SCT for malignant brain tumors in children under 3 years of age.
    Sung KW; Lim DH; Lee SH; Yoo KH; Koo HH; Kim JH; Suh YL; Joung YS; Shin HJ
    Bone Marrow Transplant; 2013 Jul; 48(7):932-8. PubMed ID: 23318534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.
    Baek HJ; Park HJ; Sung KW; Lee SH; Han JW; Koh KN; Im HJ; Kang HJ; Park KD
    J Neurooncol; 2013 Sep; 114(3):329-38. PubMed ID: 23824533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
    Fleischhack G; Pöpping K; Hasan C; Utsch B; Jüttner J; Bode U
    Klin Padiatr; 1998; 210(4):248-55. PubMed ID: 9743961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
    Sung KW; Son MH; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ; Lee SK; Choi YS; Lim DH; Kim JS; Kim DW
    Bone Marrow Transplant; 2013 Jan; 48(1):68-73. PubMed ID: 22635247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of survival in patients with high-risk neuroblastoma who failed tandem high-dose chemotherapy and autologous stem cell transplantation.
    Yi ES; Son MH; Hyun JK; Cho HW; Ju HY; Lee JW; Yoo KH; Sung KW; Koo HH
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28066. PubMed ID: 31736249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma.
    Lee JW; Lim DH; Sung KW; Cho HW; Ju HY; Hyun JK; Yoo KH; Koo HH; Suh YL; Joung YS; Shin HJ
    Cancer Med; 2020 Aug; 9(16):5807-5818. PubMed ID: 32608158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.
    Friedrich C; von Bueren AO; von Hoff K; Gerber NU; Ottensmeier H; Deinlein F; Benesch M; Kwiecien R; Pietsch T; Warmuth-Metz M; Faldum A; Kuehl J; Kortmann RD; Rutkowski S
    Neuro Oncol; 2013 Feb; 15(2):224-34. PubMed ID: 23223339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical teratoid/rhabdoid tumors in children treated with multimodal therapies: The necessity of upfront radiotherapy after surgery.
    Lee J; Kim DS; Han JW; Suh CO
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors.
    Guruangan S; Dunkel IJ; Goldman S; Garvin JH; Rosenblum M; Boyett JM; Gardner S; Merchant TE; Gollamudi S; Finlay JL
    J Clin Oncol; 1998 Jul; 16(7):2486-93. PubMed ID: 9667268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors.
    Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J
    Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
    Choi LM; Rood B; Kamani N; La Fond D; Packer RJ; Santi MR; Macdonald TJ
    Pediatr Blood Cancer; 2008 May; 50(5):970-5. PubMed ID: 17941070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.